ReproCELL Incorporated (TYO:4978)
Japan flag Japan · Delayed Price · Currency is JPY
151.00
+6.00 (4.14%)
Apr 25, 2025, 3:30 PM JST

ReproCELL Revenue

ReproCELL had revenue of 748.00M JPY in the quarter ending December 31, 2024, with 18.92% growth. This brings the company's revenue in the last twelve months to 2.72B, up 8.46% year-over-year. In the fiscal year ending March 31, 2024, ReproCELL had annual revenue of 2.43B, down -17.85%.

Revenue (ttm)
2.72B
Revenue Growth
+8.46%
P/S Ratio
5.26
Revenue / Employee
28.31M
Employees
96
Market Cap
14.30B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20242.43B-527.00M-17.85%
Mar 31, 20232.95B719.00M32.18%
Mar 31, 20222.23B948.00M73.72%
Mar 31, 20211.29B87.00M7.26%
Mar 31, 20201.20B111.00M10.20%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Chugai Pharmaceutical 1,170.61B
Takeda Pharmaceutical Company 4,579.02B
Daiichi Sankyo Company 1,795.99B
HOYA Corporation 838.60B
Terumo 1,011.15B
Otsuka Holdings 2,329.86B
Astellas Pharma 1,867.63B
Shionogi & 456.87B
Revenue Rankings